Skip to content

Inhaled Sedation Using the Anesthetic-conserving Device ( ANACONDA) in Prehospital Emergency Medecine.

Feasibility of Isoflurane Sedation Using an Anesthetic-conserving Device in Prehospital Emergency Medicine: A Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04141267
Acronym
ANACONDA
Enrollment
10
Registered
2019-10-28
Start date
2019-05-03
Completion date
2019-06-03
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Sedation, Endotracheal Intubation

Brief summary

Achieving the optimal sedation level for patient management is not always possible using our standard intravenous medications in Pre-hospital Emergency medicine. Inhaled sedation is possible with the Anesthetic-conserving device with a standard respirator. The pharmacodynamics and pharmacokinetics of halogenated agents allow deep sedation quickly after absorption. The feasibility of inhaled sedation has never been studied in hospital.

Detailed description

Retrospecive clinical monocentric study with sedated ventilated patients with isoflurane with the AnaConda® system out of hospital.

Interventions

None listed

Sponsors

University Hospital, Brest
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient sedated by isoflurane with Anesthetic-conserving device in pre-hospital * Major patient * not opposed to participating

Exclusion criteria

* Adults Under legal protection * patient refusal to participate in study

Design outcomes

Primary

MeasureTime frameDescription
depth of sedationup to 1 daydepth of sedation (measured by the Ramsay Score) 10 minutes from start of the sedation and at stop of pre hospital sedation. The Ramsay score ranges level of sedation from 1(patient anxious ,agitated,restless) to 6 (patient exhibits no response).

Secondary

MeasureTime frameDescription
hemodynamic tolerance of patients during isoflurane sedationup to 1 daycomparison of heart rate (heart beats per minute) before isoflurane start and 10 minutes from start of the sedation and at stop of pre hospital sedation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026